日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis

钠-葡萄糖协同转运蛋白2抑制剂对糖尿病状态和蛋白尿水平的影响:一项荟萃分析

Staplin, Natalie; Roddick, Alistair J; Neuen, Brendon L; Anker, Stefan D; Bhatt, Deepak L; Butler, Javed; Cherney, David Z; Docherty, Kieran F; Fletcher, Robert A; Inzucchi, Silvio E; Jardine, Meg; Mahaffey, Kenneth W; McGuire, Darren K; McMurray, John J V; Neal, Bruce; Packer, Milton; Patel, Siddharth M; Perkovic, Vlado; Sabatine, Marc S; Solomon, Scott; Vaduganathan, Muthiah; Wanner, Christoph; Wheeler, David C; Zannad, Faiez; Haynes, Richard; Heerspink, Hiddo J L; Herrington, William G

Effect of Finerenone on Morbidity and Mortality in CKD

非奈利酮对慢性肾脏病患者发病率和死亡率的影响

Ostrominski, John W; Filippatos, Gerasimos; Claggett, Brian L; Miao, Zi Michael; Desai, Akshay S; Jhund, Pardeep S; Henderson, Alasdair; Rohwedder, Katja; Brinker, Meike D; Scalise, Andrea; Schloemer, Patrick; Lam, Carolyn S P; Senni, Michele; Shah, Sanjiv J; Voors, Adriaan A; Zannad, Faiez; Rossing, Peter; Ruilope, Luis M; Anker, Stefan D; Pitt, Bertram; Agarwal, Rajiv; McMurray, John J V; Solomon, Scott D; Vaduganathan, Muthiah

Not All Weight Loss Is Equal: Towards Muscle-Preserving Therapies in Obesity

并非所有减肥方法都一样:肥胖症肌肉保护疗法研究进展

Abraham, Joseph D; Khan, Muhammad Shahzeb; Anker, Stefan D

Adipose Tissue and Lipid Dysregulation Contributions to Cachexia, Sarcopenia and Muscle Function

脂肪组织和脂质代谢紊乱对恶病质、肌肉减少症和肌肉功能的影响

Abraham, Joseph D; von Haehling, Stephan; Anker, Stefan D

Finerenone in People with CKD, Type 2 Diabetes, and History of Nephrectomy

非奈利酮在慢性肾病、2型糖尿病和肾切除史患者中的应用

Munoz Mendoza, Jair; Weir, Matthew R; Anker, Stefan D; Filippatos, Gerasimos; Rossing, Peter; Ahlers, Christiane; Brinker, Meike; Fatoba, Samuel T; Horvat-Broecker, Andrea; Rohwedder, Katja; Fornoni, Alessia

Association between functional Status and cardiac function in chronic heart failure: insights from the C-MIC II Trial

慢性心力衰竭患者的功能状态与心脏功能之间的关联:来自 C-MIC II 试验的启示

Fudim, Marat; Kovacevic-Preradovic, Tamara; Zdravkovic, Marija; Jovev, Sasko; Granov, Nermir; Popov, Tanja; Rudez, Igor; Vukovic, Petar; Ristic, Velibor; Holtdirk, Annette; Khan, Muhammad Shahzeb; Kallel, Faouzi; Peric, Miodrag; Butler, Javed; Anker, Stefan D; Kosevic, Dragana; Rame, J Eduardo

Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular-kidney-metabolic conditions: A pooled analysis of randomised trials

SGLT2抑制剂对心血管-肾脏-代谢性疾病中不同程度蛋白尿的影响:随机试验的汇总分析

Ferreira, João Pedro; Marques, Pedro; Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Sharma, Abhinav; Vasques-Nóvoa, Francisco; Mendonça, Luís; Neves, João Sérgio; Packer, Milton; Zannad, Faiez

Skeletal Muscle Mass Modifies the Prognostic Impact of LDL Cholesterol in Chronic Heart Failure

骨骼肌质量会影响低密度脂蛋白胆固醇对慢性心力衰竭预后的影响

Sato, Ryosuke; Garfias-Veitl, Tania; Fibbi, Guglielmo; Vatic, Mirela; Doehner, Wolfram; Anker, Stefan D; von Haehling, Stephan

A FIDELITY Analysis on Finerenone With SGLT-2i and GLP-1RA in CKD

一项关于非奈利酮联合SGLT-2抑制剂和GLP-1受体激动剂治疗慢性肾脏病的FIDELITY分析

Singh, Ajay K; Anker, Stefan D; Pitt, Bertram; Rossing, Peter; Ruilope, Luis M; Ahlers, Christiane; Farag, Youssef M K; Lambelet, Marc; Brinker, Meike D; Rohwedder, Katja; Filippatos, Gerasimos

Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-Pooled

恩格列净治疗心力衰竭和既往冠状动脉血运重建:来自 EMPEROR 汇总研究的启示

Dhingra, Nitish K; Butler, Javed; Anker, Stefan D; Ferreira, Joao Pedro; Filippatos, Gerasimos; Pfarr, Egon; Gasior, Tomasz; Nordaby, Matias; Brueckmann, Martina; Pocock, Stuart J; Zannad, Faiez; Packer, Milton; Verma, Subodh